Advanced Medical Solutions Group (AIM:AMS), a specialist in tissue-healing technologies, said it has received approval in the United States for LiquiBand XL, which it described as a new device that can close longer wounds than existing LiquiBand products.
Product launch in the US market is expected in the third quarter of 2022.
The AIM-traded firm said the device has been used successfully on a variety of orthopaedic procedures in multiple territories since its European approval in 2021.
Shares were up 2.13% to 283.40p today.